Feds Spent Even More on PrEP Combo Than Previously Thought New estimate says taxpayers spent over $140 million to study Truvada as HIV prevention May 02, 2023
Why Is One Dose Suddenly Enough for the mRNA COVID Vaccines? FDA and CDC have made yet another questionable decision May 02, 2023
Some Private Companies Charge Hefty Fees to Help Veterans With Disability Claims Unaccredited operators cause headaches for vets Apr 30, 2023
It's a Precarious Path From Dreamer to Doctor DACA recipients face barriers to education and practice Apr 29, 2023
FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset Apr 28, 2023
ACOG PAC Donated Over $1M to Anti-Abortion Legislators Ob/gyn organization maintains stated support for reproductive healthcare, including abortion Apr 28, 2023
More Efforts Needed to Combat Antimicrobial Resistance, Lawmakers Told Witnesses at House hearing push for new drugs and tests, and more infectious disease docs Apr 28, 2023
Patients Living With Long COVID Offer Insight to FDA Agency sought feedback on outcomes that matter most to patients Apr 28, 2023
FDA Extends Trikafta Approval to Even Younger Cystic Fibrosis Patients Patients ages 2 to 5 years now eligible for the triple therapy Apr 27, 2023
FDA OKs First Poop-Based Oral Therapy Vowst approved for preventing recurrent C. difficile infections after antibiotics Apr 27, 2023
Return of 3-Day Rule Will Stress Crowded Hospitals Further Groups call for the 57-year-old policy to be abolished Apr 26, 2023
Be Wary of Amniotic Fluid Eye Drops, FDA Says Agency sends another salvo in battle with birth-tissue industry Apr 24, 2023
FDA Finally OKs Latest MiniMed System for Type 1 Diabetes 780G system first to feature meal detection technology Apr 24, 2023
Thumbs Down From FDA Panel on Plastic Meniscus Replacement Members unimpressed with efficacy, safety data Apr 21, 2023
Who Are the Doctors Suing FDA Over the Abortion Pill? Four physicians are named as plaintiffs alongside the Alliance for Hippocratic Medicine Apr 20, 2023
FDA Panelists Slam Agency's Proposed Opioid Trial Design Advisors said outcomes from an enriched enrollment study would not be broadly generalizable Apr 20, 2023
Antibody-Drug Conjugate Gets FDA Thumbs Up for Untreated DLBCL Adding polatuzumab vedotin to a modified version of R-CHOP significantly improved PFS Apr 20, 2023
ADHD Drug Abuse in Schools; Bizarre Ozempic Dreams; COVID Ups Diabetes Risk Health news and commentary from around the Web gathered by staff Apr 19, 2023
FDA Mulling Trial Design Issues for Long-Term Opioids in Chronic Pain Agency advisors will consider pros, cons of an enriched enrollment randomized withdrawal design Apr 17, 2023
FDA Advisors Endorse Rexulti for Agitation in Alzheimer's Dementia Increased mortality risk seen but benefits may outweigh this, panelists say Apr 14, 2023
FDA Panel to Weigh Limited Data on Combo for Healthcare-Acquired Pneumonia Sulbactam-durlobactam under consideration for cases caused by Acinetobacter spp. Apr 14, 2023
All Opioid Pain Meds to Get New Safety Warnings, FDA Says Updated labeling to include warning about opioid-induced hyperalgesia Apr 13, 2023
Rexulti Works for Agitation in Alzheimer's, Despite Risks, Says FDA Staff Increased mortality risk consistent with other antipsychotics in elderly dementia patients Apr 13, 2023
The Promise of the $5 Billion Investment in 'Project Next Gen' Here's how to make it money well spent Apr 13, 2023
Reworked Philips CPAP, BiPAP Machines May Not Deliver Correct Therapy And some of the remediated breathing devices may not provide any treatment at all, FDA warns Apr 10, 2023
FDA Approval Authority in Jeopardy? TB Hits the Casino; Sen. Blumenthal's Surgery Health news and commentary from around the Web gathered by staff Apr 10, 2023
NIH's Genome Chief Says Genomics Is Evolving and Docs Need More Education on It National Human Genome Research Institute Director Eric Green sits down with Apr 07, 2023
FDA Yanks Only Preterm Birth Drug, Effective Immediately Months after advisors recommended Makena's approval be withdrawn, FDA announces final decision Apr 06, 2023
CMS Cracks Down on Medicare Advantage Marketing, Prior Auth Practices Agency wants to stop schemes that mislead beneficiaries and prohibit unfair denials of care Apr 06, 2023
New DEA License Requirement Starts in June The X waiver is gone, but clinicians may need new training to renew their DEA license Apr 05, 2023
Monopoly Be Gone: A New Chapter in U.S. Organ Procurement and Transplantation A recent announcement from HHS has the power to transform our deeply flawed system Apr 04, 2023
Mail-Back Envelopes Will Be Dispensed With Outpatient Opioid Scripts Strategy will provide another option to dispose of unneeded medications, FDA says Apr 03, 2023
Experts Call for PBM Transparency During Senate Hearing "Every drug should have a price that is accessible to every American at any time," witness argues Mar 31, 2023
Moderna's Steep COVID Vaccine Price: Corporate Greed or Capitalism? Lessons learned and next steps for public-private vaccines Mar 30, 2023
Do Away With 'Lockout' Period in iPLEDGE, FDA Advisors Urge It's an "unduly high burden" on patients, says one advisory committee member Mar 29, 2023
'No Safe Place': Shooting Hits Home for Nashville Doctors Pediatric surgeon: "Why are our children being massacred in their schools?" Mar 29, 2023
Isotretinoin REMS Still Needed, but Its Burden Could Be Reduced, FDA Staff Says Report suggests ways to lighten documentation rules for prescribing the severe acne treatment Mar 27, 2023
FDA Greenlights First Drug for Rare Immunodeficiency Disease Activated PI3K-delta syndrome may have a new standard of care Mar 27, 2023
FDA Faults Next-Gen Olympus Duodenoscopes After demanding single-use devices, agency finds they have their own problems Mar 27, 2023
FDA: Watch for Joint Replacement Device Failure After Exactech Recall Revision surgery only recommended for patients with pain Mar 23, 2023
